Answer
Synagis (palivizumab) is administered intramuscularly, preferably into the anterolateral thigh; the gluteal muscle should not routinely be used because of sciatic nerve injury risk.
Sources for this answer
- Synagis 50 mg/0.5 ml solution for injectionAstraZeneca UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked